Publication: The Quazar AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of Oral CC-486 in Patients with Acute Myeloid Leukemia (AML) in First Remission
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
WoS Q
Q4
Scopus Q
Q3
Source
Oncology Research and Treatment
Volume
43
Issue
Start Page
38
End Page
38